z-logo
Premium
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT‐PCR
Author(s) -
Hurley Michael J.,
Mash Deborah C.,
Jenner Peter
Publication year - 2003
Publication title -
european journal of neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.346
H-Index - 206
eISSN - 1460-9568
pISSN - 0953-816X
DOI - 10.1046/j.1460-9568.2003.02963.x
Subject(s) - dopamine transporter , dopaminergic , dopamine , tyrosine hydroxylase , parkinson's disease , cerebellum , dopamine receptor d3 , medicine , dopamine receptor , biology , neuroscience , endocrinology , disease
The presence of neuronal elements that are indicative of dopaminergic neurotransmission in cerebellum suggest that this brain region may contribute to the motor symptoms or dyskinesia seen in Parkinson's disease. Reverse transcription polymerase chain reaction (RT‐PCR) was used to examine the expression of markers for dopaminergic neurotransmission in the cerebellum from postmortem brain tissue obtained from normal subjects and patients dying with Parkinson's disease who were receiving treatment with dopaminergic drugs. Dopamine D 1−3 receptors, tyrosine hydroxylase and dopamine transporter mRNA was detected in the uvula and nodulus (lobules 9 and 10, respectively) of the vermis of cerebellum from normal individuals. In Parkinson's disease, the level of dopamine D 1 and D 3 receptor mRNA was significantly reduced in lobule 9 and the level of tyrosine hydroxylase mRNA was significanty reduced in lobule 10. No alteration in the level of dopamine D 2 receptor or dopamine transporter mRNA was found in either lobule in patients with Parkinson's disease. These results show that mRNA expression for the functional components of dopaminergic neurotransmission is present in human cerebellum. The discrete changes in the levels of dopamine D 1 and D 3 receptors and tyrosine hydroxylase mRNA in cerebellum from l ‐DOPA treated Parkinson's disease patients suggests that this brain area has a role in the symptoms of Parkinson's disease and/or the beneficial/side‐effects of treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here